Skip to content

The effect of remimazolam on perioperative cognitive function in elderly patients undergoing total laparoscopic hysterectomy: a randomized controlled study

The effect of remimazolam on perioperative cognitive function in elderly patients undergoing total laparoscopic hysterectomy: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077118
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative cognitive impairment

Interventions

R group:Anesthesia induction, intravenous injection of 0.3 mg/kg (1 minute) of remidazolam and 0.3 mg/kg (1 minute) of sufentanil µg/kg (30s), rocuronium 0.6mg/kg (15s)
Anesthesia maintenance, remidazolam (0.1-0.3mg/kg/h) and remifentanil (0.075-0.2 µg/kg/min).
P group:Anesthesia induction, intravenous injection of 0.3 mg/kg (1 minute) of propofol and 2 mg/kg (1 minute) of sufentanil µg/kg (30s), rocuronium 0.6mg/kg (15s)
Anesthesia maintenance, propofol (4-12mg/kg/h) and remifentanil (0.075-0.2 µg/kg/min).

Sponsors

Jinan maternal and child health care hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) No contraindications to anesthesia, ASA grading is I-III; (2) Age>60 years old, undergoing laparoscopic total hysterectomy; (3) Sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Other central nervous system diseases and infectious diseases; (2) Other underlying diseases (liver, kidney, cardiovascular system diseases); (3) Mental illness; (4) Dependence on alcohol or psychotropic substances.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination;Montreal Cognitive Assessment;

Secondary

MeasureTime frame
occurrences of respiratory suppression;dosage of remazolam;time of stop using remazolam to awake;body movement response;occurrences of hypotension;occurrences of BIS>60;score of Steward;

Countries

China

Contacts

Public ContactHan Bao

Jinan maternal and child health care hospital

baohanxmu@163.com+86 188 4427 7227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026